Archives
-
Arachidonic Acid Accelerates Vaccine Immunity
2026-09-15
The reference study shows that dietary arachidonic acid can strengthen rabies vaccine-induced humoral immunity in mice and accelerate protective neutralizing antibody responses in human volunteers. Its mechanistic contribution is the identification of a lymph node ARA–PGI2–cAMP/PKA pathway that supports CD86 expression and activation-induced cytidine deaminase in B cells.
-
Fluo-4 AM for Podocyte Calcium Signaling Assays
2026-09-14
Learn how Fluo-4 AM converts transient Ca2+ changes into actionable readouts for podocyte and diabetic nephropathy research. This workflow emphasizes matched controls, live-cell kinetics, assay normalization, and troubleshooting for mechanistic calcium signaling studies.
-
AAL-993 and the Next Logic of Tumor Angiogenesis
2026-09-14
A mechanistic and translational framework for using AAL-993 as a selective VEGF receptor inhibitor in tumor angiogenesis research, while integrating pathway-level insights from glioma studies without overstating what the evidence proves.
-
TPPU as a Mechanistic Probe of Epoxide Signaling
2026-09-13
TPPU is a potent soluble epoxide hydrolase inhibitor for dissecting fatty acid epoxide signaling, inflammatory pain, and bone-remodeling biology. This article presents an assay-centered framework that separates target engagement from downstream Nrf2 and osteoclast phenotypes.
-
Chloroquine, MrgprA3, and Sensory Research
2026-09-12
Chloroquine is more than an autophagy inhibitor: it is also a mechanistically informative pruritogen through MrgprA3-positive sensory neurons. This article translates new chronic-dermatitis findings into practical assay decisions while distinguishing sensory, immune, antiviral, and anticancer readouts.
-
Lipo3K Transfection Reagent: Assay Guide
2026-09-11
Learn how Lipo3K Transfection Reagent, SKU K2705, can help laboratories manage transfection-related variability in viability, proliferation, and cytotoxicity assays. This scenario-based guide covers difficult-to-transfect cells, DNA and siRNA workflows, protocol timing, data interpretation, and practical reagent selection.
-
Adiponectin, TLR4, and Cognitive Protection After Surgery
2026-09-11
This reference study shows that adiponectin pretreatment reduces splenectomy-associated cognitive deficits in aged rats, with parallel suppression of hippocampal TLR4/MyD88/NF-κB signaling, oxidative stress, and microglial inflammation. Pharmacological inhibition and activation of TLR4 strengthen the proposed mechanism while also highlighting the need for further validation in clinically relevant perioperative neurocognitive disorder models.
-
Regorafenib: From Kinase Blockade to RRM2
2026-09-10
Regorafenib research is moving beyond broad kinase inhibition toward mechanistic interpretation of RRM2 and ERK/E2F3 signaling. This guide connects melanoma findings with angiogenesis research, migration assays, and tumor xenograft models.
-
GW4064 for FXR Signaling: Applied Workflows
2026-09-10
GW4064 is a potent, non-steroidal FXR agonist for separating receptor-driven effects from broader stress responses in lipid, bile acid, and fibrosis models. This guide translates recent LX-2 cell findings into practical dosing, controls, readouts, and troubleshooting strategies.
-
Cand2, Ubiquitination, and Fungal Pathogenicity
2026-09-09
The reference study identifies MoCand2 as a conserved fungal inhibitor of Cullin-RING ligase-mediated ubiquitination and connects this activity to autophagy control in Magnaporthe oryzae. Its findings show that excessive ubiquitination alters MoTor and MoAtg6 regulation, enhancing autophagy while impairing fungal development, stress adaptation, and rice-infection capacity.
-
Reserpine N1867: Practical Lab Workflow
2026-09-09
Reserpine (SKU N1867) is a characterized research reagent for controlled neurotransmitter depletion research, antihypertensive mechanism studies, and related neuropharmacology workflows. This guide covers preparation, storage, quality control, and troubleshooting while clarifying that the material is for research use only, not clinical, diagnostic, or veterinary applications.
-
Selonsertib (GS-4997): Stress-to-Fibrosis Insight
2026-09-08
A translational perspective on how selective ASK1 inhibition can help researchers separate oxidative-stress signaling from the Galectin-1–FIP200 autophagy axis in metabolic liver, fibrosis, and diabetic kidney disease models.
-
I-BET151 (GSK1210151A) in Cancer Biology
2026-09-08
I-BET151 (GSK1210151A) provides a pharmacological way to test whether BET-dependent transcription supports oncogenic growth, apoptosis resistance, or enhancer-driven programs. This practical guide connects BET inhibition with super-enhancer biology, prostate cancer disulfidptosis research, and reproducible apoptosis and cell-cycle workflows.
-
Homoharringtonine: From Ribosome to Assay Design
2026-09-07
Homoharringtonine is a cytotoxic alkaloid whose translation-blocking biology connects leukemia research with SARS-CoV-2 antiviral research. This evidence-aware guide focuses on assay architecture, interpretation, and the limits of translating ribosome inhibition across disease models.
-
PINK1 Loss, Mitochondrial Iron, and Colon Tumors
2026-09-07
The reference study identifies mitochondrial iron accumulation as a targetable consequence of PINK1 deficiency in colorectal tumor models. By integrating transcriptomics, iron imaging, pharmacological chelation, and MCU manipulation, it connects defective mitophagy with iron-driven tumor growth and supports further investigation of iron-reducing strategies in PINK1-low disease.